1. Home
  2. BFS vs HELP Comparison

BFS vs HELP Comparison

Compare BFS & HELP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Saul Centers Inc.

BFS

Saul Centers Inc.

SELL

Current Price

$29.56

Market Cap

902.2M

Sector

Real Estate

ML Signal

SELL

Logo Cybin Inc. Common Stock

HELP

Cybin Inc. Common Stock

HOLD

Current Price

$10.50

Market Cap

862.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BFS
HELP
Founded
1993
2019
Country
United States
Canada
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
902.2M
862.2M
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
BFS
HELP
Price
$29.56
$10.50
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
11
Target Price
★ $43.00
$40.33
AVG Volume (30 Days)
133.2K
★ 1.7M
Earning Date
11-05-2026
11-12-2026
Dividend Yield
★ 8.10%
N/A
EPS Growth
N/A
★ N/A
EPS
★ 0.50
N/A
Revenue
★ $289,843,000.00
N/A
Revenue This Year
$7.44
N/A
Revenue Next Year
$3.40
N/A
P/E Ratio
$58.28
★ N/A
Revenue Growth
★ 7.81
N/A
52 Week Low
$29.06
$3.76
52 Week High
$38.42
$15.15

Technical Indicators

Market Signals
Indicator
BFS
HELP
Relative Strength Index (RSI) 34.79 42.05
Support Level N/A $4.41
Resistance Level $35.04 $14.75
Average True Range (ATR) 0.63 0.81
MACD 0.07 -0.16
Stochastic Oscillator 21.49 19.53

Price Performance

Historical Comparison
BFS
HELP

About BFS Saul Centers Inc.

Saul Centers Inc is a self-managed real estate investment trust which invests in, operates and develops retail and commercial properties. The company's portfolio includes community and neighbourhood shopping centres, office properties, and mixed-use properties. Properties are located in the Washington, D.C. and Batlimore metropolitan areas. Saul Centers operates through two business segments: Shopping Centers segment, which contribute the maximum portion of total revenue; and mixed-use properties.Mixed-Use Properties segment include office, retail and multi-family residential use.

About HELP Cybin Inc. Common Stock

Helus Pharma Inc, the commercial operating name of Cybin Inc, is a clinical-stage pharmaceutical company focused on developing proprietary neuroactive compounds, referred to as NSAs, which are synthetic molecules designed to target serotonin pathways. The company's programs are aimed at treating mental health conditions such as depression and anxiety. Its pipeline includes HLP003, which is in clinical development for the adjunctive treatment of depressive disorder, and HLP004, which is in clinical development for generalized anxiety disorder. The company also conducts research on additional investigational compounds.

Share on Social Networks: